|
1
|
Miller KD, Nogueira L, Devasia T, Mariotto
AB, Yabroff KR, Jemal A, Kramer J and Siegel RL: Cancer treatment
and survivorship statistics, 2022. CA Cancer J Clin. 72:409–436.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cao M, Shi E, Wang H, Mao L, Wu Q, Li X,
Liang Y, Yang X, Wang Y and Li C: Personalized targeted therapeutic
strategies against oral squamous cell carcinoma. An evidence-based
review of literature. Int J Nanomedicine. 17:4293–4306. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma-an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khachigian LM: The MEK-ERK-Egr-1 axis and
its regulation in cardiovascular disease. Vascul Pharmacol.
153:1072322023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thomes PG and Donohue TM: Role of early
growth response-1 in the development of alcohol-induced steatosis.
Curr Mol Pharmacol. 10:179–185. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Truong V, Jain A, Anand-Srivastava MB and
Srivastava AK: Angiotensin II-induced histone deacetylase 5
phosphorylation, nuclear export, and Egr-1 expression are mediated
by Akt pathway in A10 vascular smooth muscle cells. Am J Physiol
Heart Circ Physiol. 320:H1543–H1554. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shao S, Ju M, Lei J, Lu X, Li H, Wang D
and Xia C: Egr-1 inhibits colon cancer cell proliferation,
migration and invasion via regulating CDKL1 at the transcriptional
level. Oncol Rep. 46:1692021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sheng J, Liu D, Kang X, Chen Y, Jiang K
and Zheng W: Egr-1 increases angiogenesis in cartilage via binding
Netrin-1 receptor DCC promoter. J Orthop Surg Res. 13:1252018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi F, Wang X, Zhao S, Wang C, Sun R, Wang
H, Du P, Wang J, Wang X and Jiang G: miR-let-7c-3p targeting on
Egr-1 contributes to the committed differentiation of leukemia
cells into monocyte/macrophages. Oncol Lett. 24:2732022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen W, Zhao S, Xing J, Yu W, Rao T, Zhou
X, Ruan Y, Li S, Xia Y, Song T, et al: BMAL1 inhibits renal
fibrosis and renal interstitial inflammation by targeting the
ERK1/2/ELK-1/Egr-1 axis. Int Immunopharmacol. 125:1111402023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu J, Tao W, Bu D, Zhao Y, Zhang T, Chong
D, Xue B, Xing Z and Li C: Egr-1 transcriptionally activates
protein phosphatase PTP1B to facilitate hyperinsulinemia-induced
insulin resistance in the liver in type 2 diabetes. FEBS Lett.
593:3054–3063. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SM, Park MS, Park SY, Choi YD, Chung
JO, Kim DH, Jung YD and Kim HS: Primary bile acid activates Egr-1
expression through the MAPK signaling pathway in gastric cancer.
Mol Med Rep. 25:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oh S, Kim H, Nam K and Shin I: Egr-1 is
required for neu/HER2-induced mammary tumors. Cell Signal.
45:102–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei LL, Wu XJ, Gong CC and Pei DS: Egr-1
suppresses breast cancer cells proliferation by arresting cell
cycle progression via down-regulating CyclinDs. Int J Clin Exp
Pathol. 10:10212–10222. 2017.PubMed/NCBI
|
|
16
|
Chuang KC, Chen FW, Tsai MH and Shieh JJ:
EGR-1 plays a protective role in AMPK inhibitor compound C-induced
apoptosis through ROS-induced ERK activation in skin cancer cells.
Oncol Lett. 21:3042021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Shepherd EG and Nelin LD: MAPK
phosphatases-regulating the immune response. Nat Rev Immunol.
7:202–212. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang TT, Wang Y, Zhang XW, Yang KY, Miao
XQ and Zhao GH: MiR-200c-3p regulates DUSP1/MAPK pathway in the
nonalcoholic fatty liver after laparoscopic sleeve gastrectomy.
Front Endocrinol (Lausanne). 13:7924392022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou X, Li L, Chen S, Ge C, Shen M and Fu
Z: MKP-1 overexpression reduces postischemic myocardial damage
through attenuation of ER stress and mitochondrial damage. Oxid Med
Cell Longev. 2021:89055782021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang X, Jiang Y, Li J, Wang Y, Tian Y, Guo
Q and Cheng Z: DUSP1 promotes microglial polarization toward M2
phenotype in the medial prefrontal cortex of neuropathic pain rats
via inhibition of MAPK pathway. ACS Chem Neurosci. 12:966–978.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilczek MP, Armstrong FJ, Geohegan RP,
Mayberry CL, DuShane JK, King BL and Maginnis MS: The MAPK/ERK
pathway and the role of DUSP1 in JCPyV infection of primary
astrocytes. Viruses. 13:18342021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang D and Jiang Y: MKP1 reduces
neuroinflammation via inhibiting endoplasmic reticulum stress and
mitochondrial dysfunction. J Cell Physiol. 235:4316–4325. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge Y, Wang J, Wu D, Zhou Y, Qiu S, Chen J,
Zhu X, Xiang X, Li H and Zhang D: lncRNA NR_038323 suppresses renal
fibrosis in diabetic nephropathy by targeting the miR-324-3p/DUSP1
axis. Mol Ther Nucleic Acids. 17:741–753. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye Y, Bao C and Fan W: Overexpression of
miR-101 may target DUSP1 to promote the cartilage degradation in
rheumatoid arthritis. J Comput Biol. 26:1067–1079. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sanders BE, Yamamoto TM, McMellen A,
Woodruff ER, Berning A, Post MD and Bitler BG: Targeting DUSP
activity as a treatment for high-grade serous ovarian carcinoma.
Mol Cancer Ther. 21:1285–1295. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martinez-Martinez D, Toledo Lobo MV,
Baquero P, Ropero S, Angulo JC, Chiloeches A and Lasa M:
Downregulation of snail by DUSP1 impairs cell migration and
invasion through the inactivation of JNK and ERK and is useful as a
predictive factor in the prognosis of prostate cancer. Cancers
(Basel). 13:11582021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai X, Qu L, Yang J, Xu J, Sun L, Wei X,
Qu X, Bai T, Guo Z and Zhu Y: Exosome-transmitted microRNA-133b
inhibited bladder cancer proliferation by upregulating
dual-specificity protein phosphatase 1. Cancer Med. 9:6009–6019.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Zhang L, Liu FY, Li P, He J,
Kirkwood CL, Sohn J, Chan JM, Magner WJ and Kirkwood KL: MKP-1 is
required to limit myeloid-cell mediated oral squamous cell
carcinoma progression and regional extension. Oral Oncol.
120:1054012021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan S, Shen M, Zhou M, Shi X, He R, Yin T,
Wang M, Guo X and Qin R: Long noncoding RNA LINC01111 suppresses
pancreatic cancer aggressiveness by regulating DUSP1 expression via
microRNA-3924. Cell Death Dis. 10:8832019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pan W, Han J, Wei N, Wu H, Wang Y and Sun
J: LINC00702-mediated DUSP1 transcription in the prevention of
bladder cancer progression: Implications in cancer cell
proliferation and tumor inflammatory microenvironment. Genomics.
114:1104282022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Han J, Liu X and Wang L: Dexmedetomidine
protects against acute lung injury in mice via the DUSP1/MAPK/NF-κB
axis by inhibiting miR-152-3p. Pulm Pharmacol Ther.
1021312022.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee S, Hwang Y, Kim TH, Jeong J, Choi D
and Hwang J: UPF1 inhibits hepatocellular carcinoma growth through
DUSP1/p53 signal pathway. Biomedicines. 10:7932022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lane R, Cilibrasi C, Chen J, Shah K,
Messuti E, Mazarakis NK, Stebbing J, Critchley G, Song E, Simon T
and Giamas G: PDGF-R inhibition induces glioblastoma cell
differentiation via DUSP1/p38MAPK signalling. Oncogene.
41:2749–2763. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chandrashekar DS, Karthikeyan SK, Korla
PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne
U, et al: UALCAN: An update to the integrated cancer data analysis
platform. Neoplasia. 25:18–27. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reis PP, Waldron L, Perez-Ordonez B,
Pintilie M, Galloni NN, Xuan Y, Cervigne NK, Warner GC, Makitie AA,
Simpson C, et al: A gene signature in histologically normal
surgical margins is predictive of oral carcinoma recurrence. BMC
Cancer. 11:4372011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wasserman WW and Sandelin A: Applied
bioinformatics for the identification of regulatory elements. Nat
Rev Genet. 5:276–287. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xu K, Meng Z, Xian XM, Deng MH, Meng QG,
Fang W, Zhang D and Long X: LncRNA PVT1 induces chondrocyte
apoptosis through upregulation of TNF-α in synoviocytes by sponging
miR-211-3p. Mol Cell Probes. 52:1015602020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang LF, Liu YS, Yang B, Li P, Cheng XS,
Xiao CX, Liu JJ, Li S, Ren JL and Guleng B: The extracellular
matrix protein mindin attenuates colon cancer progression by
blocking angiogenesis via Egr-1-mediated regulation. Oncogene.
37:601–615. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tseng YC, Shu CW, Chang HM, Lin YH, Tseng
YH, Hsu HS, Goan YG and Tseng CJ: Assessment of early growth
response 1 in tumor suppression of esophageal squamous cell
carcinoma. J Clin Med. 11:57922022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun SW, Fang XM, Li YF, Wang QB and Li YX:
Expression and clinical significance of EGR-1 and PTEN in the
pituitary tumors of elderly patients. Oncol Lett. 14:2165–2169.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peng WX, Xiong EM, Ge L, Wan YY, Zhang CL,
Du FY, Xu M, Bhat RA, Jin J and Gong AH: Egr-1 promotes
hypoxia-induced autophagy to enhance chemo-resistance of
hepatocellular carcinoma cells. Exp Cell Res. 340:62–70. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Peng WX, Wan YY, Gong AH, Ge L, Jin J, Xu
M and Wu CY: Egr-1 regulates irradiation-induced autophagy through
Atg4B to promote radioresistance in hepatocellular carcinoma cells.
Oncogenesis. 6:e2922017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Myung E, Park YL, Kim N, Chung CY, Park
HB, Park HC, Myung DS, Kim JS, Cho SB, Lee WS and Joo YE:
Expression of early growth response-1 in human gastric cancer and
its relationship with tumor cell behaviors and prognosis. Pathol
Res Pract. 209:692–699. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pang Z, Raudonis R, McCormick C and Cheng
Z: Early growth response 1 deficiency protects the host against
pseudomonas aeruginosa lung infection. Infect Immun. 88:e00678–19.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zagurovskaya M, Shareef MM, Das A, Reeves
A, Gupta S, Sudol M, Bedford MT, Prichard J, Mohiuddin M and Ahmed
MM: EGR-1 forms a complex with YAP-1 and upregulates Bax expression
in irradiated prostate carcinoma cells. Oncogene. 28:1121–1131.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu WS, You RI, Cheng CC, Lee MC, Lin TY
and Hu CT: Snail collaborates with EGR-1 and SP-1 to directly
activate transcription of MMP 9 and ZEB1. Sci Rep. 7:177532017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lei S, He X, Yang X, Gu X, He Y and Wang
J: A mechanism study of DUSP1 in inhibiting malignant progression
of endometrial carcinoma by regulating ERK/AP-1 axis and
dephosphorylation of EPHA2. J Cancer. 14:634–645. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Goda C, Balli D, Black M, Milewski D, Le
T, Ustiyan V, Ren X, Kalinichenko VV and Kalin TV: Loss of FOXM1 in
macrophages promotes pulmonary fibrosis by activating p38 MAPK
signaling pathway. PLoS Genet. 16:e10086922020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yin Y, Wang S, Sun Y, Matt Y, Colburn NH,
Shu Y and Han X: JNK/AP-1 pathway is involved in tumor necrosis
factor-alpha induced expression of vascular endothelial growth
factor in MCF7 cells. Biomed Pharmacother. 63:429–435. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Qi M, Sun LA, Zheng LR, Zhang J, Han YL,
Wu F, Zhao J, Niu WH, Fei MX, Jiang XC and Zhou ML: Expression and
potential role of FOSB in glioma. Front Mol Neurosci.
15:9726152022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yuan D, Fang Y, Chen W, Jiang K, Zhu G,
Wang W, Zhang W, You G, Jia Z and Zhu J: ZFP36 inhibits tumor
progression of human prostate cancer by targeting CDK6 and
oxidative stress. Oxid Med Cell Longev. 2022:36115402022.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Tang TP, Qin CX and Yu H: MCM3AP-AS1
regulates proliferation, apoptosis, migration, and invasion of
breast cancer cells via binding with ZFP36. Transl Cancer Res.
10:4478–4488. 2021. View Article : Google Scholar : PubMed/NCBI
|
